通过XIAP下调抑制RIPK2在全方位化中介的胰岛素抵抗
Endocrine connections
|December 16, 2025
概括
与受体相互作用的氨酸-氨酸激酶2 (RIPK2) 在2型糖尿病中驱动胰岛素抵抗 (IR). 与X相关的亡抑制剂 (XIAP) 缺乏会降低RIPK2的无化,使IR恶化. 准RIPK2可以治疗T2DM.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 胰岛素抵抗 (IR) 是2型糖尿病 (T2DM) 发病的一个关键因素.
- 与受体相互作用的氨酸-氨酸激酶2 (RIPK2) 已涉及到调解IR.
研究的目的:
- 调查RIPK2在IR发展中的特殊作用.
- 在细胞模型中探索RIPK2,X链接的亡抑制剂 (XIAP) 和IR之间的关系.
主要方法:
- 通过使用棕酸在老鼠L6髓管中建立了体外IR模型.
- 评估了RIPK2和XIAP表达,氧化应激标记 (SOD,CAT,GPx,MDA) 和信号通路激活 (ERK1/2,p38,AKT).
- 在对RIPK2和XIAP进行基因操纵后,量化了RIPK2的无处不在和葡萄糖摄取量.
主要成果:
- 在IR模型中,RIPK2表达增加,而XIAP表达下降.
- RIPK2过度表达加剧了氧化应激,改变了MAPK信号传递,减少了葡萄糖摄取,并降低了AKT酸化.
- 过度表达XIAP增强了葡萄糖吸收和AKT酸化,而XIAP则调解了RIPK2的无化.
结论:
- 缺少XIAP导致RIPK2无化减少,有助于T2DM的胰岛素抵抗.
- RIPK2在介导红外线方面发挥着关键作用,可能通过氧化应激和关键信号通路的调制.
- 调节RIPK2活动或XIAP水平可能为T2DM提供治疗策略.
相关概念视频
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
Insulin: The Receptor and Signaling Pathways
2.6K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.6K
Dipeptidyl Peptidase 4 Inhibitors
557
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
557
Receptor Downregulation in MVBs
2.7K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.7K


